Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Aspergillus oryzae is a filamentous fungus widely utilized in various industrial applications, particularly in food fermentation for products like soy sauce, miso, and sake. Beyond its traditional uses, it serves as a significant source for enzymes such as acid lactase, triacylglycerol lipase, and beta-galactosidase, which are employed in dietary supplements and food processing. Furthermore, iron-enriched Aspergillus oryzae has been developed as a vehicle for iron supplementation to address iron deficiency anemia, offering potentially improved absorption and fewer side effects compared to inorganic iron salts. The fungus also produces bioactive compounds, including ergosta-4,6,8(14),22-tetraen-3-one (ETO) with anti-inflammatory properties, and macrocyclic sesterterpenoids exhibiting antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Aspergillus oryzae.